Suven Pharmaceuticals Limited (BOM: 543064)
India
· Delayed Price · Currency is INR 1,180.90
0.00 (0.00%)
At close: Dec 20, 2024
Suven Pharmaceuticals Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 19, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 |
| Market Capitalization | 301,698 | 172,366 | 120,256 | 157,436 | 126,468 | 25,590 | Upgrade
|
| Market Cap Growth | 108.96% | 43.33% | -23.62% | 24.49% | 394.21% | - | Upgrade
|
| Enterprise Value | 296,034 | 165,176 | 117,048 | 156,449 | 127,128 | 25,590 | Upgrade
|
| Last Close Price | 1180.90 | 676.60 | 472.70 | 608.03 | 483.61 | 98.13 | Upgrade
|
| PE Ratio | 124.10 | 57.40 | 29.24 | 34.69 | 34.90 | 8.07 | Upgrade
|
| PS Ratio | 31.07 | 16.39 | 8.97 | 11.92 | 12.53 | 3.07 | Upgrade
|
| PB Ratio | 14.72 | 8.41 | 6.93 | 10.31 | 10.71 | 3.03 | Upgrade
|
| P/TBV Ratio | 17.50 | 8.67 | 7.19 | 10.32 | 10.73 | 3.04 | Upgrade
|
| P/FCF Ratio | 158.44 | 56.20 | 70.21 | 61.78 | 46.55 | 8.42 | Upgrade
|
| P/OCF Ratio | 105.20 | 48.08 | 26.30 | 47.71 | 33.06 | 6.29 | Upgrade
|
| EV/Sales Ratio | 30.80 | 15.71 | 8.73 | 11.85 | 12.59 | 3.07 | Upgrade
|
| EV/EBITDA Ratio | 91.28 | 40.65 | 20.44 | 27.00 | 28.85 | 6.70 | Upgrade
|
| EV/EBIT Ratio | 111.18 | 46.59 | 22.24 | 28.88 | 31.01 | 7.14 | Upgrade
|
| EV/FCF Ratio | 157.08 | 53.86 | 68.34 | 61.40 | 46.79 | 8.42 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.03 | 0.04 | 0.06 | 0.12 | 0.22 | Upgrade
|
| Debt / EBITDA Ratio | 0.12 | 0.16 | 0.12 | 0.17 | 0.32 | 0.49 | Upgrade
|
| Debt / FCF Ratio | 0.21 | 0.21 | 0.41 | 0.38 | 0.53 | 0.61 | Upgrade
|
| Asset Turnover | 0.42 | 0.50 | 0.71 | 0.80 | 0.76 | 0.85 | Upgrade
|
| Inventory Turnover | 1.67 | 1.60 | 1.87 | 2.24 | 2.19 | 1.93 | Upgrade
|
| Quick Ratio | 3.58 | 9.46 | 4.17 | 3.85 | 1.56 | 0.98 | Upgrade
|
| Current Ratio | 4.90 | 11.82 | 6.37 | 5.36 | 2.57 | 1.95 | Upgrade
|
| Return on Equity (ROE) | 12.25% | 15.86% | 25.21% | 33.52% | 35.78% | 44.18% | Upgrade
|
| Return on Assets (ROA) | 7.20% | 10.50% | 17.33% | 20.49% | 19.35% | 22.90% | Upgrade
|
| Return on Capital (ROIC) | 8.21% | 11.30% | 19.18% | 22.96% | 21.76% | 26.29% | Upgrade
|
| Earnings Yield | 0.81% | 1.74% | 3.42% | 2.88% | 2.87% | 12.39% | Upgrade
|
| FCF Yield | 0.63% | 1.78% | 1.42% | 1.62% | 2.15% | 11.87% | Upgrade
|
| Dividend Yield | 0.00% | - | - | 0.33% | 0.41% | 1.27% | Upgrade
|
| Payout Ratio | 0.00% | - | 49.52% | 11.22% | 7.03% | 10.04% | Upgrade
|
| Buyback Yield / Dilution | -0.10% | - | - | - | 0.00% | -0.00% | Upgrade
|
| Total Shareholder Return | -0.10% | - | - | 0.33% | 0.41% | 1.27% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.